Covera Health
United States
- New York, NY
- 02/11/2023
- Series C
- $50,000,000
At Covera, we’re committed to ensuring high-quality healthcare is more than just a promise. That’s why we’re leading the way in the emerging science of quality, and connecting providers and payers in their shared quest to improve patient outcomes and care quality. By tackling this challenge, we have the ability to impact millions of lives by raising the standard of care nationwide.
Our initial focus is radiology, where an early and accurate diagnosis has a profound impact on the rest of a patient’s care journey. Through our work, which uses clinically-validated science-based tools, we’re helping doctors enhance their care, ensuring patients get the right diagnosis, and enabling the healthcare system to support quality improvement at scale.
Through our clinical intelligence platform, we have launched programs that help people access the most effective care and provide doctors with AI-powered quality insights and tools to enhance their care. Today, Covera is partnered with leading employers, payers and healthcare organizations across the US, including Walmart and Microsoft. And, with a pipeline representing over 25% of insured Americans, we are in the early stages of improving care quality for all patients across the globe.
In August 2021, we raised a $25M Series C financing round with Insight Partners, a leading global venture capital and private equity firm investing in high-growth companies driving transformative change in their industries.
- Industry Hospital & Health Care
- Website https://www.coverahealth.com/
- LinkedIn https://www.linkedin.com/company/covera-health/about/
Related People
Ron VianuFounder
United States -
New York City Metropolitan Area
Passionate about transforming healthcare, my focus is on aligning providers and payers through a supportive ecosystem, designed to meet their unique needs and ultimately improve patient care. At Covera Health, we utilize clinical-grade AI and data science, within a Patient Safety Organization (PSO), to enhance diagnostic accuracy and reduce medical errors. I'm proud to lead a venture-backed team of dedicated professionals who share this vision. If our mission resonates, we'd love to hear from you.
Option Circle | $3,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Chowbus | $81,000,000 | (Mar 12, 2026)
zymtrace | $12,200,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
Xscape Photonics Inc | $37,000,000 | (Mar 12, 2026)
Swarm Aero | $35,000,000 | (Mar 12, 2026)
anchr | $5,800,000 | (Mar 12, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)